{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:29:26Z","timestamp":1792672166399,"version":"4.5.0"},"reference-count":37,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>The key role in the development of cerebral vasospasm after subarachnoid hemorrhage (SAH) is increasingly assigned to endothelin (ET)-1. Constriction of the cerebrovasculature by ET-1 is mainly mediated by the ET<jats:sub>A<\/jats:sub> receptor but is putatively altered during the development of cerebral vasospasm. Therefore, the aim in the present study was to characterize these alterations, with the emphasis on the ET<jats:sub>A<\/jats:sub> receptor.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Cerebral vasospasm was induced using the rat double-hemorrhage model and proven by perfusion weighted magnetic resonance imaging. Rats were killed on Day 5 after SAH, and immunohistochemical staining for ET<jats:sub>A<\/jats:sub> receptors was performed. The isometric force of basilar artery ring segments with (E+, control group) and without (E\u2212, SAH group) endothelial function was measured. Concentration effect curves (CECs) for ET-1 were constructed by cumulative application in the absence and presence of the selective ET<jats:sub>A<\/jats:sub> receptor antagonist clazosentan (10<jats:sup>\u22128<\/jats:sup> or 10<jats:sup>\u22127<\/jats:sup> M).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The CEC for E+ segments was significantly shifted to the left after SAH by a factor of 3.7, whereas maximum contraction was unchanged. In E\u2212 segments, the CECs were not shifted during cerebral vasospasm but the maximum contraction was significantly enhanced. The inhibitory potency of clazosentan yielded a pA2 value of 8.6 \u00b1 0.2. Immunohistochemical staining of the smooth-muscle layer showed no significant increase of ET<jats:sub>A<\/jats:sub> receptor expression, but positive staining occurred in the endothelial space after SAH.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The present data indicate an enhanced contractile effect of the smooth-muscle ET<jats:sub>A<\/jats:sub> receptors in cases of cerebral vasospasm. The inhibitory potency of clazosentan on this contraction is increased. Furthermore, some evidence for an ETA receptor and an endothelium-dependent vasoactive effect after SAH is provided.<\/jats:p><\/jats:sec>","DOI":"10.3171\/jns-07\/07\/0121","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:54:27Z","timestamp":1201179267000},"page":"121-127","source":"Crossref","is-referenced-by-count":31,"title":["Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function"],"prefix":"10.3171","volume":"107","author":[{"given":"Hartmut","family":"Vatter","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Konczalla","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Weidauer","sequence":"additional","affiliation":[{"name":"Institute for Neuroradiology, Johann Wolfgang Goethe-University, Frankfurt am Main; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Preibisch","sequence":"additional","affiliation":[{"name":"Institute for Neuroradiology, Johann Wolfgang Goethe-University, Frankfurt am Main; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Duisburg-North, Duisburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Raabe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Seifert","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00006123-199707000-00039","article-title":"Impairment of the modulatory role of nitric oxide on the endothelin-1-elicited contraction of cerebral arteries: a pathogenetic factor in cerebral vasospasm after subarachnoid hemorrhage?","volume":"41","author":"Alabadi","year":"1997"},{"key":"b2-1070121","series-title":"Acta Physiol Scand","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1748-1716.1990.tb08852.x","article-title":"Enhanced vasoconstrictor effect of endothelin in cerebral arteries from rats with subarachnoid haemorrhage","volume":"138","author":"Alafaci","year":"1990"},{"key":"b3-1070121","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1136\/jnnp.2004.036921","article-title":"Tissue at risk concept for endovascular treatment of severe vasospasm after aneurysmal subarachnoid haemorrhage","volume":"75","author":"Beck","year":"2004"},{"key":"b4-1070121","series-title":"Hypertension","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/01.HYP.0000117296.30296.14","article-title":"ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats","volume":"43","author":"Callera","year":"2004"},{"key":"b5-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/00006123-200212000-00002","article-title":"Endothelin receptor antagonists and cerebral vasospasm: an update","volume":"51","author":"Chow","year":"2002"},{"key":"b6-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1227\/01.NEU.0000068863.37133.9E","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation","volume":"53","author":"Dumont","year":"2003"},{"key":"b7-1070121","series-title":"Cleve Clin J Med","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3949\/ccjm.62.2.105","article-title":"New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelinnitric oxide network","volume":"62","author":"Ehrenreich","year":"1995"},{"key":"b8-1070121","series-title":"Res Exp Med (Berl)","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s004330050042","article-title":"Endothelium-dependent relaxation counteracting the contractile action of endothelin-1 is partly due to ETB receptor activation","volume":"196","author":"Feger","year":"1997"},{"key":"b9-1070121","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/S031716710003403X","article-title":"Causes of morbidity and mortality following intracranial aneurysm rupture","volume":"25","author":"Findlay","year":"1998"},{"key":"b10-1070121","series-title":"Neurosurgery","first-page":"1188","article-title":"Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries","volume":"52","author":"Hansen-Schwartz","year":"2003"},{"key":"b11-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1227\/01.NEU.0000144866.28101.6D","article-title":"Perfusion-weighted magnetic resonance imaging in patients with vasospasm: a useful new tool in the management of patients with subarachnoid hemorrhage","volume":"56","author":"Hertel","year":"2005"},{"key":"b12-1070121","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/00004647-199607000-00020","article-title":"Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys","volume":"16","author":"Hino","year":"1996"},{"key":"b13-1070121","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.STR.28.3.660","article-title":"Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review","volume":"28","author":"Hop","year":"1997"},{"key":"b14-1070121","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3171\/jns.1994.81.5.0759","article-title":"Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model","volume":"81","author":"Itoh","year":"1994"},{"key":"b15-1070121","series-title":"Exp Biol Med (Maywood)","first-page":"1064","article-title":"Alteration of the cerebrovascular function of endothelin B receptor after subarachnoidal hemorrhage in the rat","volume":"231","author":"Konczalla","year":"2006"},{"key":"b16-1070121","series-title":"Neurosurg Rev","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10143-005-0013-5","article-title":"Management of cerebral vasospasm","volume":"29","author":"Macdonald","year":"2006"},{"key":"b17-1070121","article-title":"Prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage with clazosentan, an endothelin receptor antagonist","author":"Macdonald","year":"2006"},{"key":"b18-1070121","series-title":"Am J Physiol Heart Circ Physiol","doi-asserted-by":"publisher","first-page":"H2329","DOI":"10.1152\/ajpheart.00911.2005","article-title":"Calcium sensitivity of vasospastic basilar artery after experimental subarachnoid hemorrhage","volume":"290","author":"Macdonald","year":"2006"},{"key":"b19-1070121","series-title":"Trends Pharmacol Sci","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tips.2004.02.008","article-title":"Historical review: Endothelin","volume":"25","author":"Masaki","year":"2004"},{"key":"b20-1070121","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3171\/jns.2003.98.2.0319","article-title":"Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion","volume":"98","author":"Rabinstein","year":"2003"},{"key":"b21-1070121","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/01.STR.30.3.599","article-title":"Diffusion-and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage","volume":"30","author":"Rordorf","year":"1999"},{"key":"b22-1070121","series-title":"J Pharmacol Exp Ther","first-page":"1110","article-title":"Ro 61\u20131790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm","volume":"283","author":"Roux","year":"1997"},{"key":"b23-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1227\/00006123-199507000-00012","article-title":"The role of endothelin in experimental cerebral vasospasm","volume":"37","author":"Roux","year":"1995"},{"key":"b24-1070121","series-title":"Pharmacol Rev","first-page":"325","article-title":"Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology","volume":"46","author":"Rubanyi","year":"1994"},{"key":"b25-1070121","series-title":"Cerebrovasc Brain Metab Rev","first-page":"131","article-title":"Endothelins and the cerebral circulation","volume":"7","author":"Salom","year":"1995"},{"key":"b26-1070121","series-title":"Peptides","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0196-9781(99)00179-5","article-title":"Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery","volume":"21","author":"Schilling","year":"2000"},{"key":"b27-1070121","series-title":"Crit Care Med","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/00003246-199506000-00004","article-title":"Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study","volume":"23","author":"Solenski","year":"1995"},{"key":"b28-1070121","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/01.STR.16.1.58","article-title":"Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model","volume":"16","author":"Solomon","year":"1985"},{"key":"b29-1070121","series-title":"Acta Neurochir Suppl (Wien)","first-page":"71","article-title":"Arachidonic acid release and permeability changes induced by endothelins in human cerebromicrovascular endothelium","volume":"60","author":"Stanimirovic","year":"1994"},{"key":"b30-1070121","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/jns.2005.103.1.0009","article-title":"Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study","volume":"103","author":"Vajkoczy","year":"2005"},{"key":"b31-1070121","series-title":"Arch Int Pharmacodyn Ther","first-page":"299","article-title":"Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters","volume":"143","author":"Van Rossum","year":"1963"},{"key":"b32-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1227\/01.NEU.0000249212.96719.95","article-title":"Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage","volume":"60","author":"Vatter","year":"2007"},{"key":"b33-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1227\/01.NEU.0000199346.74649.66","article-title":"Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model","volume":"58","author":"Vatter","year":"2006"},{"key":"b34-1070121","series-title":"Methods Find Exp Clin Pharmacol","first-page":"277","article-title":"Experimental approaches to evaluate endothelin-A receptor antagonists","volume":"26","author":"Vatter","year":"2004"},{"key":"b35-1070121","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3171\/jns.2005.102.6.1101","article-title":"Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin(A) receptor-mediated contraction","volume":"102","author":"Vatter","year":"2005"},{"key":"b36-1070121","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3171\/jns.2005.102.6.1108","article-title":"Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: effect on endothelin(B) receptor-mediated relaxation","volume":"102","author":"Vatter","year":"2005"},{"key":"b37-1070121","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/00006123-199810000-00083","article-title":"Endothelin and subarachnoid hemorrhage: an overview","volume":"43","author":"Zimmermann","year":"1998"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/107\/1\/article-p121.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/107\/1\/article-p121.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/107\/1\/article-p121.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T01:20:46Z","timestamp":1681348846000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/107\/1\/article-p121.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":37,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/jns-07\/07\/0121","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}